Latest News & Posts

Latest articles and news regarding the developing technology. Stay updated with the recent posts.
Acuamark Diagnostics, An Early-Cancer Detection Company, Announces Change to Its Board of Directors
April 21, 2020

Acuamark Diagnostics, An Early-Cancer Detection Company, Announces Change to Its Board of Directors

NEW YORK — Apr 21, 2020 — Acuamark Diagnostics, Inc. (“AcuamarkDx”), a biotechnology company that focuses on developing innovative blood-based screening assays for reliable and cost-effective detection of early-stage cancer, today announced the appointment of William Gedale as its Executive Chairman. Mr. Gedale will replace Mr. Michael...
Acuamark Diagnostics, An Early-Cancer Detection Company, Raises Financing
December 27, 2019

Acuamark Diagnostics, An Early-Cancer Detection Company, Raises Financing

NEW YORK — Dec 27, 2019 — Acuamark Diagnostics, Inc. (“Acuamark”), a biotechnology company that focuses on developing innovative blood-based screening assays for reliable and cost-effective detection of early-stage cancer, today announced that it has completed private placement of its Preferred Series AA3 stock in a round that was subs...
National Academy of Inventors Announces 2016 Fellows
December 13, 2016

National Academy of Inventors Announces 2016 Fellows

TAMPA, Fla., Dec. 13, 2016 /PRNewswire/ -- The National Academy of Inventors (NAI) has named 175 leaders of academic invention to NAI Fellow status.
Do I Have a Hidden Cancer?
October 13, 2016

Do I Have a Hidden Cancer?

In its early stages, cancer is usually asymptomatic. Early detection is a complex challenge. Can a blood sample detect early signs?
Acuamark Diagnostics Raising Funds to Finance Early Detection Dx Development
October 13, 2016

Acuamark Diagnostics Raising Funds to Finance Early Detection Dx Development

NEW YORK (GenomeWeb) – Last month, iCareDx announced that it was rebranding itself as Acuamark Diagnostics as it works to raise funds for its first round of clinical testing.
Early-Cancer Detection Company iCareDx Announces Corporate Name Change To Acuamark Diagnostics
September 22, 2016

Early-Cancer Detection Company iCareDx Announces Corporate Name Change To Acuamark Diagnostics

Globally, over 22,000 people die of cancer each day. When cancer is detected at the early stages, survival rates are generally still high. Finding cancer early with an accurate, convenient and affordable technology, and attacking it early, can vastly reduce cancer deaths, and substantially lower cancer-related healthcare expenditures.
Acuamark Diagnostics develops technology that allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before cancer becomes untreatable.

© 2020 AcuamarkDx | All Rights Reserved | Privacy Policy | Sitemap | Designed By: MedTech Momentum